About the honoree
Dr. Reshma Kewalramani is the Chief Executive Officer and President of Vertex Pharmaceuticals, a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. Vertex has multiple approved medicines that treat the underlying causes of Cystic Fibrosis and other rare diseases.
Dr. Kewalramani is an accomplished leader and physician with a track record of building strong teams, putting patients first, leading change and delivering results.
As an immigrant and alumnus of two Massachusetts universities, Dr. Kewalramani’s life and contributions to science exemplify the ingenuity and global leadership that benefits the United States in remaining open to brilliant minds from around the world. As the first female CEO of a top five biotech firm, she is inspiring people across generations and industries
For her successful efforts to provide life-saving medicines to people with rare diseases and for her leadership of one of the world’s premier biotechnology companies, the International Institute of New England proudly presents the 39th Golden Door Award to Dr. Reshma Kewalramani.